IPC Classification

All sections
A - Human necessities
A61K - Preparations for medical, dental or toiletry purposes
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans

Patent holdings for IPC class A61K 38/17

1204	1434	1453	1385	1525	1497	1318	1265	1191	584
2017	2018	2019	2020	2021	2022	2023	2024	2025	2026

Owner	All patents	This class
The Regents of the University of California	20720	361
The Board of Trustees of the Leland Stanford Junior University	6644	207
Immatics Biotechnologies GmbH	1127	153
Regeneron Pharmaceuticals, Inc.	4698	149
Inserm (institut National de La Sante et de La Recherche Medicale)	3337	146
The Trustees of the University of Pennsylvania	4414	141
Acceleron Pharma Inc.	341	134
Centre National de La Recherche Scientifique	11016	122
The United States of America, as represented by the Secretary, Department of Health and Human Services	2999	120
The General Hospital Corporation	4858	107
Dana-Farber Cancer Institute, Inc.	2662	107
The Johns Hopkins University	5875	105
Institut National de La Sante et de La Recherche Medicale (inserm)	3219	102
President and Fellows of Harvard College	6091	99
Board of Regents, The University of Texas System	6102	95
Novartis AG	10263	92
Children's Medical Center Corporation	1956	89
Modernatx, Inc.	1291	83
The Brigham and Women's Hospital, Inc.	2282	79
Massachusetts Institute of Technology	10239	68
Other owners		15581